ResultsIQ

ResultsIQ › Latest results › 3M India Limited

3M India Limited strategy deck summary

NSE: 3MINDIA · BSE: 523395

Strategy deck of 12 Mar 2026, summarised by AI from the filing.

3M India FY 2024-25 sales were ₹4,446 cr and YTD Q3 FY2025-26 sales grew 13.6%, with Aseem Joshi becoming Managing Director effective 1 April 2026.

Key takeaways

  1. Sales FY 2024-25 sales were ₹4,446 cr; YTD Q3 FY2025-26 sales grew 13.6%.
  2. Guidance No forward-looking guidance was given in the presentation.
  3. Growth strategy Strategies for growth include commercial excellence, local R&D, local supply chain and talent & organization.
  4. Risk Forward-looking statements involve risks and uncertainties that could cause actual outcomes to differ materially.

Original filing on BSE

3M India Limited Q1 FY27 results

As filed: Revenue ₹1,423 cr (+19% year on year), EBITDA ₹238 cr (−1% year on year), PAT ₹233 cr (−4% year on year), EBITDA margin 16.7% (−342 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹1,399 cr (+17% year on year), EBITDA ₹257 cr (+14% year on year), PAT ₹215 cr (+11% year on year), EBITDA margin 18.4% (−46 bps). Score 56 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA growth was in line with it; profit before exceptional items growth was below it. EBITDA margin fell 46 bps year on year. Share price after the results: +2.9% in 28 days (Nifty 500: +2.4%).
  • Q3 FY26: Revenue ₹1,228 cr (+13% year on year), EBITDA ₹231 cr (+50% year on year), PAT −₹62.1 cr (+23% year on year), EBITDA margin 18.8% (+466 bps). Score 67 of 100, Above trend. Revenue growth was in line with the company's own trend; EBITDA growth was well above it; profit before exceptional items growth was above it. EBITDA margin rose 466 bps year on year. Tax rate 154%. Profit fell 25% from last quarter. Share price after the results: −12.2% in 29 days (Nifty 500: −10.1%).
  • Q2 FY26: Revenue ₹1,266 cr (+14% year on year), EBITDA ₹256 cr (+40% year on year), PAT ₹191 cr (+43% year on year), EBITDA margin 20.2% (+375 bps). Score 77 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 375 bps year on year. Share price after the results: +13.2% in 30 days (Nifty 500: −0.4%).
  • Q1 FY26: Revenue ₹1,196 cr (+20% year on year), EBITDA ₹241 cr (+24% year on year), PAT ₹178 cr (+22% year on year), EBITDA margin 20.2% (+55 bps). Score 75 of 100, Above trend. Revenue and EBITDA growth were well above the company's own trend; profit growth was above it. EBITDA margin rose 55 bps year on year. Share price after the results: −1.6% in 29 days (Nifty 500: +0.7%).
  • Q4 FY25: Revenue ₹1,198 cr (+16% year on year), EBITDA ₹226 cr (+12% year on year), PAT ₹71.0 cr (−56% year on year), EBITDA margin 18.9% (−69 bps). Score 45 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was above it; profit growth was well below it. EBITDA margin fell 69 bps year on year. Tax rate 68%. Profit fell 38% from last quarter. Share price after the results: −4.7% in 30 days (Nifty 500: +3.5%).
  • Q3 FY25: Revenue ₹1,090 cr (+16% year on year), EBITDA ₹154 cr (−8% year on year), PAT ₹114 cr (−9% year on year), EBITDA margin 14.1% (−360 bps). Score 37 of 100, Below trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 360 bps year on year. Profit fell 15% from last quarter.
  • Q2 FY25: Revenue ₹1,111 cr (+14% year on year), EBITDA ₹183 cr (+2% year on year), PAT ₹134 cr (0% year on year), EBITDA margin 16.5% (−189 bps). Score 39 of 100, Below trend. EBITDA margin fell 189 bps year on year. Not enough history for a trend yet: scored on growth alone. Profit fell 8% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

3M India Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.